Whittier Trust Co. lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 23.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,469 shares of the biotechnology company's stock after purchasing an additional 3,649 shares during the period. Whittier Trust Co.'s holdings in Axon Enterprise were worth $11,571,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in the stock. Groupama Asset Managment purchased a new position in Axon Enterprise during the third quarter worth about $200,000. Massachusetts Financial Services Co. MA acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $120,553,000. Proficio Capital Partners LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter valued at approximately $78,414,000. Westfield Capital Management Co. LP lifted its holdings in Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock valued at $469,661,000 after acquiring an additional 127,769 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its position in Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company's stock worth $86,354,000 after acquiring an additional 111,405 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Axon Enterprise Stock Up 0.8 %
Shares of AXON traded up $4.66 during midday trading on Tuesday, hitting $577.18. The company had a trading volume of 439,520 shares, compared to its average volume of 835,219. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The firm has a market capitalization of $44.23 billion, a P/E ratio of 149.14, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company's 50-day simple moving average is $591.98 and its 200-day simple moving average is $545.11.
Analyst Ratings Changes
Several brokerages have recently commented on AXON. TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target on the stock. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. Robert W. Baird boosted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Finally, JMP Securities reaffirmed an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $604.67.
Check Out Our Latest Research Report on AXON
Insider Buying and Selling at Axon Enterprise
In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company's stock.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
